Frontiers in Neurology (Nov 2022)

Case report: Reversible encephalopathy associated with liposomal amphotericin B in a patient with cryptococcal meningitis

  • Si Luo,
  • Han Wen,
  • Meihong Zhou,
  • Chengsi Wu,
  • Daojun Hong

DOI
https://doi.org/10.3389/fneur.2022.1019137
Journal volume & issue
Vol. 13

Abstract

Read online

Liposomal amphotericin B (L-AMB) is an anti-fungus medicine that has fewer side effects than traditional amphotericin B (AMB). Neurotoxicity of L-AMB has rarely been observed, and only one case of leukoencephalopathy during intravenous L-AMB has been reported. Herein, we described a patient with cryptococcal meningitis presenting with late-onset reversible encephalopathy associated with liposomal amphotericin B.

Keywords